N. Desai

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.

J. Mascola, T. Pierson, R. Koup, 2011, The Journal of infectious diseases.

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.

J. Mascola, R. Koup, C. Andrews, 2010, Vaccine.

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.

J. Mascola, T. Pierson, R. Koup, 2011, The Journal of infectious diseases.